Authors:
Monali Tayade, Jignesh Rawal
Download free PDF
Implantable Cardioverter Defibrillators Market Size & Share 2024 to 2032
Report ID: GMI7696
|
Published Date: December 2023
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Jump to Content
Market Size
Market Trends
Market Analysis
Market Share
Market Companies
Industry News
Table of Contents
Frequently Asked Questions
Research Methodology
Related Reports
Download Free PDF
Implantable Cardioverter Defibrillators Market
Get a free sample of this report
Get a free sample of this report Implantable Cardioverter Defibrillators Market
Is your requirement urgent? Please give us your business email
for a speedy delivery!
Implantable Cardioverter Defibrillators Market Size
Implantable Cardioverter Defibrillators Market was valued at over USD 8.8 billion in 2023 and is anticipated to grow at a CAGR of over 6.4% between 2024 & 2032. This robust market growth can be attributed to various factors, including the rising incidences of cardiovascular diseases, growing geriatric population, continual technological advancements in ICDs, and increasing worldwide healthcare spending among others are supporting the market growth.
Implantable Cardioverter Defibrillators Market Key Takeaways
Moreover, the rise in the prevalence of cardiovascular disorders, such as ventricular arrhythmias and heart failure, is among a major driving factor for the ICD industry. As these conditions are substantial risk factors for sudden cardiac death, there is a growing demand for ICDs as a preventative and therapeutic treatment. For instance, according to American Heart Association, ischemic heart disease (IHD) affected around 244 million individuals globally in 2020, with men suffering more than females (141 and 103 million individuals), respectively. Additionally, the growing focus on preventive cardiology and the management of individuals at risk of sudden cardiac death promotes the use of ICDs as a preventive measure. Early intervention with ICDs can significantly improve patient outcomes.
An implantable cardioverter defibrillators is a specialized, implantable medical device designed to monitor and regulate the heart's rhythm. It is primarily used to treat life-threatening ventricular arrhythmias, such as ventricular fibrillation (VF) and ventricular tachycardia (VT), that can lead to sudden cardiac arrest. The ICD continuously monitors the heart's electrical activity, and when it detects an abnormal rhythm, it can deliver therapeutic interventions, such as electrical shocks (defibrillation) or pacing, to restore a normal and coordinated heartbeat.
COVID-19 Impact
The COVID-19 pandemic had a notable impact on the implantable cardioverter defibrillators market. While lockdowns and resource reallocation caused immediate disruptions in elective surgeries and medical device manufacturing, the long-term impacts showed an increased understanding of the value of remote monitoring technology. During the pandemic, with an upsurge towards telehealth and remote patient care, the integration of remote monitoring capabilities in ICDs gained importance, providing a solution for remotely monitoring patients and reducing the need for in-person follow-ups. In addition, the focus on meeting the healthcare requirements of COVID-19 patients resulted in a temporary decrease in non-COVID-related elective treatments. However, the industry witnessed surged up product demand post the initial decline, thus, supporting the market growth.
Implantable Cardioverter Defibrillators Market Trends
Growing demand for combination ICD devices with pacemaker functionality, increased focus on patient-centric care, continuous advancements in wireless charging and battery technology are among the key variables propelling the product demand. Additionally, surging need for integration of artificial intelligence (AI) in healthcare and data analytics into ICD systems are other factors that are contributing to the evolving landscape of the implantable cardioverter defibrillators industry.
Implantable Cardioverter Defibrillators Market Analysis
The market by product is segmented into transvenous implantable cardioverter-defibrillators and subcutaneous implantable cardioverter defibrillators. The transvenous ICD segment accounted for majority revenue share and was valued at around USD 6.8 billion revenue in 2023.
Based on type, the market is categorized into single-chamber ICDs, dual-chamber ICDs, and biventricular devices. The biventricular devices segment dominated the implantable cardioverter defibrillators market and accounted for over 42% market share in 2023 and is anticipated to witness significant growth during the forecast period.
The implantable cardioverter defibrillators industry by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment accounted for over USD 4.5 billion revenue in 2023.
North America implantable cardioverter defibrillators market accounted for USD 4.7 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
Implantable Cardioverter Defibrillators Market Share
The implantable cardioverter defibrillators industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Medtronic plc, BIOTRONIK SE & Co. KG, and Boston Scientific Corporation, among others have a notable presence in the market.
Implantable Cardioverter Defibrillators Market Companies
Some of the eminent market participants operating in the implantable cardioverter defibrillators industry include:
Implantable Cardioverter Defibrillators Industry News:
Implantable cardioverter defibrillators market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Type
Market, By End-use
The above information is provided for the following regions and countries:
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Implantable Cardioverter Defibrillators Industry Insights
Chapter 4 Competitive Landscape, 2023
Chapter 5 Implantable Cardioverter Defibrillators Market Size and Forecast, By Product, 2018-2032 (USD Million)
Chapter 6 Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2018-2032 (USD Million)
Chapter 7 Implantable Cardioverter Defibrillators Market Size and Forecast, By End-use, 2018-2032 (USD Million)
Chapter 8 Implantable Cardioverter Defibrillators Market Size and Forecast, By Region, 2018-2032 (USD Million)
Chapter 9 Company Profiles
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →